汉森制药：2025年的营收占比相关情况将在2025年年度报告中披露

Core Viewpoint - Hansen Pharmaceutical indicated that the revenue distribution for 2024 will be detailed in the annual report, with the Southwest region (including the Tibetan area) contributing 16.31% to the overall revenue, while the Tibetan area's contribution is relatively small [2] Group 1 - The company will provide details on the revenue distribution for 2025 in its future annual report [2] - The Southwest region's revenue contribution is significant, accounting for 16.31% of total revenue [2] - The Tibetan area's revenue contribution within the Southwest region is noted to be small [2]